Work

One target, two evidence streams: Rituximab versus ocrelizumab in relapsing multiple sclerosis: A design-stratified systematic review, meta-analysis, and concordance assessment

Year: 2026

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Multiple Sclerosis and Related Disorders

DOI: 10.1016/j.msard.2026.107934

Authors: Yehia Nabil, Ahmed Shaheen, Anas Mansour, Enas Kamal Abdalaziz Seyed, Baraah abu alsel, Safya E. Esmaeel, Mostafa Meshref, Ram Saha

Institutions: Zagazig University, Alexandria University, Al-Azhar University, Al-Neelain University, North Private College of Nursing, Northern Border University, Virginia Commonwealth University

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7213633784

FWCI:

Cites: 22

Cited by:

Related to: 10